The Blood Grouping Reagents Market in Australia showed a decreasing trend from 2013 to 2023. In 2023, the market value stood at 10.169 million US dollars. The market has experienced a consistent decline over the years, with a particularly sharp drop observed from 2016 to 2017 at a rate of -20.86%. The trend of declining values continues into forecasted years, with an expected further reduction by 2028, marking a forecasted 5-year CAGR of -12.26% and an estimated decline of -48.01% from 2023. Over the last five years, the market's average annual decline rate was -7.54%.

Future trends to watch for:

Advancements in alternative technologies and methodologies for blood grouping.
Market impact of regulatory changes in the healthcare sector.
Increasing demand for automation and rapid testing solutions in hospitals and clinics.
Potential mergers and acquisitions among key market players aiming for market consolidation.
Economic factors and healthcare budget constraints possibly affecting market growth.